Bionano Genomics, Inc. a leading genomics company, has recently announced the full commercial release of their Stratys system for high throughput optical genome mapping (OGM). This system is expected to revolutionize the field of genomics by offering a more accurate and efficient method of mapping genomes.
January 23, 2024 - San Diego, California - Bionano Genomics, Inc. made the significant announcement that their Stratys system is now available for commercial use. The Stratys system utilizes optical genome mapping (OGM) technology, which allows for the high-throughput mapping of genomes. This breakthrough technology has the potential to transform various industries, including healthcare and agriculture.
OGM is a powerful technique that provides researchers with a comprehensive view of the structure of genomes. By utilizing nano-channel arrays and fluorescent labels, the Stratys system enables the direct visualization of DNA molecules. This allows scientists to identify structural variations, such as insertions, deletions, and inversions, within a genome. The high throughput feature of the Stratys system makes it possible to analyze thousands of genomes simultaneously, significantly accelerating genomic studies.
In addition to its accuracy and efficiency, the Stratys system offers several advantages over traditional genome mapping techniques. It eliminates the need for time-consuming and expensive DNA amplification processes, thus reducing both cost and time requirements. Furthermore, the Stratys system can map genomes without the need for reference sequences, which is particularly beneficial for researchers working with novel or complex genomes.
Bionano Genomics has been at the forefront of OGM technology, and the release of the Stratys system marks a significant milestone for the company. With its full commercial availability, researchers and scientists around the world will now have access to this groundbreaking technology, enhancing the progress and advancements in genomics research.
The Stratys system has already garnered attention from both academia and industry, as its capabilities have the potential to impact various fields. In healthcare, the precise mapping of genomes can aid in the identification of disease-causing genetic variations, leading to improved diagnosis and personalized treatment options. Additionally, the Stratys system’s high throughput capabilities make it a valuable tool for screening large populations, facilitating advances in population genetics and epidemiology research.
The agricultural sector can also benefit greatly from the Stratys system. By accurately mapping the genomes of crop plants, researchers can identify genetic variations that contribute to desired traits such as disease resistance and higher yields. This knowledge can then be applied to breeding programs, resulting in the development of new and improved crop varieties.
With the full commercial release of the Stratys system, Bionano Genomics has positioned itself as a leading player in the genomics industry. The company’s commitment to advancing OGM technology opens up new possibilities for researchers and paves the way for significant discoveries in various fields.
Comments